Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01107860 · ClinicalTrials.gov registry record
Cone Beam Computed Tomography for Breast Imaging
A clinical trial of Breast Cancer, sponsored by Koning Corporation.
- Completed
- Registry status
- 401
- Enrollment target
- 1
- Study location
NCT01107860: Completed study of Breast Cancer, sponsored by Koning Corporation.
NCT01107860 is a study of Breast Cancer that has completed, run by Koning Corporation. The registered enrollment target is 401 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01107860, a study of Breast Cancer, has completed, sponsored by Koning Corporation.
- COMPLETED
- Registry status
- 401 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to continue the investigation of cone beam computed tomography (CBCT) for breast imaging already underway in the diagnostic setting by providing a compelling body of evidence incorporating non-contrast CBCT in the study protocol. The goal is to accumulate a body of evidence to provide data to incorporate CBCT into the diagnostic work-up of breast lesions.
Primary Outcome
The primary measure of this study will include the following aspects. * the capacity of CBCT to image the breast in its entirety as compared with the gold standard mammographic exam * patient's comfort during the CBCT exam vs the mammographic exam * the concordance and discordance of CBCT breast imaging with standard mammography and other breast-imaging studies * the concordance and discordance of CBCT breast imaging with histopathology * number of participants with adverse events as a measure
Conditions Studied
Interventions
- DEVICE Computed Tomography
Study Locations (1)
New York
- Elizabeth Wende Breast Care - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-06 |
What the finished NCT01107860 record still lists
NCT01107860 is an observational study that tracks outcomes without assigning an intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Computed Tomography is the first listed.
NCT01107860 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01107860 about?
NCT01107860 is a clinical study titled "Cone Beam Computed Tomography for Breast Imaging". The primary aim of this study is to continue the investigation of cone beam computed tomography (CBCT) for breast imaging already underway in the diagnostic setting by providing a compelling body of evidence incorporating non-contrast CBCT in the study protocol. The goal is to accumulate a body of e...
What is the current status of trial NCT01107860?
This trial is currently completed. The enrollment target is 401 participants. The study started on 2010-01. Estimated completion is 2013-06.
What conditions does trial NCT01107860 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01107860?
The interventions under investigation include: Computed Tomography (DEVICE).
Who is sponsoring clinical trial NCT01107860?
This trial is sponsored by Koning Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01107860 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01107860's enrollment target sits among peer trials
401 232nd of 1224 higher than 993 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia